![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1463733
Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå ¿¹Ãø(2030³â) : Áö¿ªº° ºÐ¼® - À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°South & Central America Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User (Hospitals and Ambulatory Surgical Centers) |
Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº 2022³â¿¡ 2¾ï 8,251¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2030³â¿¡´Â 8¾ï 7,378¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2022-2030³âÀÇ CAGRÀº 15.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÃÀå ±â¾÷ÀÇ Àü·«Àû ±¸»óÀÌ Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀ» Áö¿ø
¼¼°è ·¹º§·Î ºñ¸¸ÀÇ À¯º´·üÀÌ °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ºñ¸¸ ¼ö¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ ½ÃÀå ±â¾÷ÀÌ ºñ¸¸ ¼ö¼ú½Ã µµ¿òÀÌ µÇ°í, ¾çÈ£ÇÑ °á°ú¸¦ ÃÊ·¡Çϴ ÷´Ü Á¦Ç° °³¹ßÀ» À§ÇØ Á¦Ç°ÀÇ ¹ß¸Å ¹× Àü·«Àû Á¦ÈÞ¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù Á¦Ç°ÀÇ ¹ß¸Å, ÇÕº´, Àμö µî ´Ù¾çÇÑ µ¿ÇâÀÌ ÀÖ¾ú½À´Ï´Ù. ±× Áß ¸î °¡Áö¸¦ ¾Æ·¡¿¡ ¼Ò°³ÇÕ´Ï´Ù. :
µû¶ó¼ Á¦Ç° Ãâ½Ã, °³¹ß ¹× Àü·«Àû Á¦ÈÞÀÇ ±ÞÁõÀº ÇâÈÄ ºñ¸¸ ¼ö¼ú Àåºñ ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ °¡Á®¿Ã °¡´É¼ºÀÌ ³ô½À´Ï´Ù.
Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå °³¿ä
Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ Áß³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀº ÁÖ·Î °Ç°°ú º¹Áö¿¡ °üÇÑ ÀǽÄÀÇ Çâ»ó¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù.
Biomaterials Research Àú³Î¿¡ °ÔÀçµÈ ±â»ç¿¡ µû¸£¸é 2020³â ºê¶óÁúÀº ¼¼°è¿¡¼ ´ç´¢º´ ȯÀÚ°¡ °¡Àå ¸¹Àº 10°³±¹ Áß 5À§¸¦ Â÷ÁöÇß½À´Ï´Ù. ±¹Á¦ÀûÀÎ Ã߻꿡 µû¸£¸é 2030³â±îÁö ºê¶óÁúÀÇ ´ç´¢º´ À¯º´·üÀº 6%¿¡¼ 7.8%·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñ¸¸Àº ´ç´¢º´ÀÇ ÁÖ¿ä À§Çè ¿ä¼ÒÀ̸ç, ºñ¸¸ ¼ö¼úÀÇ ½ÃÇàÀ¸·Î ÀÌ À§Çè ¿ä¼Ò¸¦ °ü¸®ÇÒ ¼ö ÀÖÀ¸¹Ç·Î ºê¶óÁúÀÇ ºñ¸¸ ¼ö¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¿©·¯ ½ÃÀå ±â¾÷ÀÌ À¯±âÀû Àü·«À» äÅÃÇϰí ÀÖÀ¸¸ç, 2022³â 10¿ù ºê¶óÁú º¸°Ç ±ÔÁ¦±â°üÀÎ ANVISA´Â AllurionÀÌ À§ dz¼± ±â¼úÀΠŸ¿øÇü dz¼±À» ºê¶óÁú¿¡¼ Ãâ½ÃÇÒ ¼ö ÀÖµµ·Ï ½ÂÀÎÇß½À´Ï´Ù. Ÿ¿øÇü dz¼±Àº ¼ö¼ú, ¸¶Ãë, ³»½Ã°æ °Ë»ç ¾øÀÌ À§Àå¿¡ »ðÀÔÇϰí Á¦°ÅÇÒ ¼ö ÀÖ½À´Ï´Ù.
Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀÇ ¸ÅÃâ°ú 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)
Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå ¼¼ºÐÈ
Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, ±¹°¡·Î ¼¼ºÐȵ˴ϴÙ.
À¯Çüº°·Î´Â Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº Á¶Àý °¡´ÉÇÑ À§¹êµå(AGB), ½½¸®ºêÀ§ ÀýÁ¦¼ú, À§ ¹ÙÀÌÆÐ½º, ½ÊÀÌÁöÀå ½ºÀ§Ä¡ ºÎÂø ´ãÃéÀüȯ¼ú(BPD-DS), ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2022³â¿¡´Â ½½¸®ºêÀ§ ÀýÁ¦¼ú ½ÃÀå ºÎ¹®ÀÌ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
ÃÖÁ¾»ç¿ëÀÚÀÇ °üÁ¡À¸·ÎºÎÅÍ Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº º´¿ø°ú ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ·Î 2ºÐµË´Ï´Ù. º´¿ø ºÎ¹®ÀÌ 2022³â¿¡ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î º¸¸é Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ºê¶óÁúÀº 2022³â¿¡ Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
Conmed Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, Reshape Lifesciences Inc´Â Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå¿¡¼ »ç¾÷À» ¿î¿µÇϰí ÀÖ´Â ´ë±â¾÷ÀÇ ÀϺÎÀÔ´Ï´Ù.
¸ñÂ÷
The South & Central America bariatric surgeries market was valued at US$ 282.51 million in 2022 and is expected to reach US$ 873.78 million by 2030; it is estimated to grow at a CAGR of 15.2% from 2022 to 2030.
Strategic Initiatives by Market Players Fuels the South & Central America Bariatric Surgeries Market
There has been a constant increase in the prevalence of obesity on a global level that has increased the demand for bariatric surgery devices. Various market players are also focused on product launches or strategic collaborations for the development of advanced products that help during bariatric surgeries and provide positive outcomes. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below:
Thus, a surge in product launches, development, and strategic collaborations is likely to create considerable growth opportunities for the bariatric surgery devices market in the future.
South & Central America Bariatric Surgeries Market Overview
The South & Central America bariatric surgeries market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is primarily attributed increasing awareness regarding health and well-being.
According to an article published in Biomaterials Research, in 2020, Brazil is among the 10 countries in the world with the highest number of people with diabetes and was ranked 5th. By 2030, the prevalence of diabetes in the country is expected to increase from 6% to 7.8%, according to international estimates. Obesity is the major risk factor for diabetes, which is taken care of by performing bariatric surgeries, thereby driving the demand for bariatric surgery devices in Brazil.
Several market players are adopting organic strategies to stay competitive in the market. In October 2022, the Brazilian Health Regulatory Agency ANVISA approved Allurion to launch its gastric balloon technology-the Elipse Balloon-in Brazil. The Elipse Balloon can be placed in the stomach and removed without surgical procedure, anesthesia, or endoscopy.
South & Central America Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Bariatric Surgeries Market Segmentation
The South & Central America bariatric surgeries market is segmented into type, end user, and country.
Based on type, the South & Central America bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.
In terms of end user, the South & Central America bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.
Based on country, the South & Central America bariatric surgeries market is segmented Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bariatric surgeries market in 2022.
Conmed Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, and Reshape Lifesciences Inc are some of the leading companies operating in the South & Central America bariatric surgeries market.
Table of Content